文献速递糖尿病

1型糖尿病病程超过50年的心血管疾病与死亡风险:FinnDiane 50年研究

Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes Study.
PubMed 文献 · Diabetes Care · 2021-06-23

基于FinnDiane研究中729例1型糖尿病病程超过50年的患者,评估心血管疾病累积发病率和死亡率及其危险因素。结果显示60年心血管疾病累积发病率为64.3%,标化发病比为7.4,标化死亡比为3.2;糖化血红蛋白及其变异性、血脂异常、体重指数、肾脏疾病等与心血管疾病相关,优化血糖控制对预防心血管疾病和超额死亡至关重要。

要点

  • 1型糖尿病病程超过50年者心血管疾病风险显著增高,标化发病比为7.4。
  • 60年心血管疾病累积发病率为64.3%,正常白蛋白尿者标化发病比为4.9。
  • 糖化血红蛋白及其变异性、血脂异常、体重指数和肾脏疾病与心血管疾病相关。

核心结论

  • 1型糖尿病病程极长者的心血管疾病风险高,优化血糖控制对预防心血管疾病和超额死亡至关重要。

研究设计与样本

  • 从FinnDiane研究的5396例中选取729例1967年及以前诊断且1型糖尿病病程超过50年的患者,并与12710例匹配的非糖尿病个体比较。
  • 从基线 visit 起中位随访16.6年(基线时糖尿病中位病程39年),评估心血管疾病累积发病率、标化发病比、标化死亡比及病因特异性风险比。

主要发现

  • 糖尿病病程超过50年者从诊断起60年心血管疾病累积发病率为64.3%(95%CI 62.5-66.0)。
  • 与非糖尿病个体相比,心血管疾病标化发病比为7.4(6.5-8.3);正常白蛋白尿者标化发病比为4.9(4.0-5.9)。
  • 与心血管疾病 incident 相关的变量包括平均HbA1c、HbA1c变异性、血脂异常、BMI、肾脏疾病、年龄和糖尿病病程;HbA1c尤其与周围动脉疾病(PAD)相关。
  • 与芬兰背景人群相比,标化死亡比为3.2(2.8-3.7)。
  • 与死亡相关的因素包括糖尿病病程、HbA1c变异性增加、炎症、胰岛素抵抗、肾脏疾病和PAD。

临床怎么用

  • 对1型糖尿病病程极长者应持续强化血糖控制,并关注HbA1c变异性、血脂、体重和肾脏疾病等风险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to determine the incidence of cardiovascular disease (CVD) and mortality as well as their risk factors in type 1 diabetes (T1D) of >50 years' duration. RESEARCH DESIGN AND METHODS: From 5,396 individuals included in the Finnish Diabetic Nephropathy Study (FinnDiane), 729 diagnosed in 1967 or earlier survived with T1D for >50 years. In this FinnDiane 50-year cohort, cumulative incidence of CVD events was assessed from the diagnosis of diabetes, and the excess CVD risk, compared with 12,710 matched individuals without diabetes. In addition, risk factors for different types of CVD (both nonfatal and fatal) and mortality were analyzed, and cause-specific hazard ratios were estimated during a median follow-up of 16.6 years from the baseline visit (median duration of diabetes 39 years at baseline). RESULTS: In individuals with diabetes duration of >50 years, the 60-year cumulative incidence of CVD from the diagnosis of diabetes was 64.3% (95% CI 62.5-66.0). Compared with individuals without diabetes, the standardized incidence ratio for CVD was 7.4 (6.5-8.3); in those with normoalbuminuria, it was 4.9 (4.0-5.9). Mean HbA1c and HbA1c variability, dyslipidemia, BMI, kidney disease, age, and diabetes duration were the variables associated with incident CVD. In particular, HbA1c was associated with peripheral artery disease (PAD). The standardized mortality ratio compared with the Finnish background population was 3.2 (2.8-3.7). The factors associated with mortality were diabetes duration, increased HbA1c variability, inflammation, insulin resistance, kidney disease, and PAD. CONCLUSIONS: Individuals with T1D of very long duration are at a high risk of CVD. In addition, throughout the lifespan, optimal glycemic control remains central to CVD and excess mortality prevention.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Harjutsalo V, Barlovic DP, Gordin D, et al. Presence and Determinants of Cardiovascular Disease and Mortality in Individuals With Type 1 Diabetes of Long Duration: The FinnDiane 50 Years of Diabetes Study. Diabetes Care. 2021. PMID: 34162664. doi:10.2337/dc20-2816

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。